GCAC and Blair Medical Group Collaborate to Champion Veteran Wellness
 | |||||||||
 |  |  |  | ||||||
Innovative Healthcare Solutions Bridge the Gap for Veterans and First Responders
Vancouver, British Columbia, Canada – TheNewswire - January 11, 2024 – Global Compliance Applications Corp. (“GCAC” or the “Company”) (CSE:APP) (FSE:2FA) (OTCQB:FUAPF), a leader in chain-of-custody compliance and data platforms, proudly announces the Blair Medical Group will join GCAC’s Citizen Green Project [1]. This collaboration is dedicated to advancing the health and growth of veterans through legal and safe natural wellness solutions.
Co-founded by Dr. Philip Blair, a respected retired US Army Colonel and disabled veteran, Blair Medical Group [2] brings decades of medical experience and a deep understanding of the endocannabinoid system. The Group focuses on aiding veterans, active duty personnel, and first responders who require non-psychoactive, legal wellness alternatives due to legal constraints and the need for non-impairing solutions.
Says Brad Moore, CEO of GCAC, "Our collaboration with Dr. Blair is a significant leap in empowering veterans. With the Efixii Uplift app, we are not just connecting veterans to quality products but also engaging them in a community that values their growth and healing. Together, we are building a future where wellness is accessible and supported by the best of technology and medical expertise.”
In the spirit of this mission, Blair Medical Group will soon offer Efixii NFT coupons for their most sought-after products, including the BCPlus Liposomal Blend, BCPlus Immunity Blend Capsules, and BCPlus Topical Gel. Each product, crafted with precision by Dr. Blair and his team, targets key wellness concerns for our veterans, from pain and inflammation to stress and immune support, without compromising their safety or compliance needs.
-
https://www.blairmedicalgroup.biz/
About Global Compliance Applications Corp. “GCAC”
GCAC is a global leader in designing and developing innovative blockchain technologies and machine learning solutions to improve real-world businesses. GCAC's leading solution is Efixii, an Ethereum Layer 2 blockchain and EVM programming functionality that is on par with other Layer-2's, such as Polygon. GCAC can quickly connect each participant from product producers, distributors, manufacturers and retailers through a series of value chain dApps that allows for data connectivity to drive better consumer experiences and sales. GCAC serves as a one-stop digital-coupon shop that saves users money on cannabis and CBD that have Efixii-blockchain verified seed to sale lifecycle information. GCAC also created clearESG to assist businesses in communicating their sustainability goals and earned attributes on the blockchain through a series of ESG (Environmental, Social & Governance) merit badges. As an interconnected supply chain solution, Efixii awards tokens for attesting to a product's value. GCAC works in many agricultural industries providing a value-added blockchain offering through a cost-effective SaaS licensing model.
For more information, please visit globalcompliance.app, or review its profile on sedar.com and the Canadian Securities Exchange thecse.com.
GCAC Press Contact
+1 (800) 409-5679
Forward-Looking Information
This news release may include forward-looking information within the meaning of Canadian securities legislation concerning the business of GCAC. Forward-looking information is based on certain key expectations and assumptions made by the management of GCAC. Although management of the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because GCAC can give no assurance that they will prove to be correct. Forward-looking statements contained in this news release are made as of the date of this news release. GCAC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy and accuracy of this information.
###